Physician profile
Sarah E Winter
NPI 1568516821
$1,065.49
in general payments reported to CMS, 2019-2025
15 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $356 · 2023: $328 · 2024: $18.52 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.90 |
| Education | $190.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $242.38 | 2023-2025 | Veozah |
| Abbvie INC. | $198.79 | 2021-2023 | |
| Evofem Biosciences, INC. | $135.20 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $134.20 | 2022-2024 | |
| Exact Sciences Corporation | $70.79 | 2023 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $60.73 | 2021-2022 | |
| Smith+Nephew, INC. | $57.13 | 2022 | |
| Organon LLC | $39.31 | 2022 | |
| Exeltis, USA INC. | $22.98 | 2023 | Slynd |
| Sumitomo Pharma America, INC. | $21.44 | 2023 | Myfembree |
| Pfizer INC. | $20.70 | 2022 | |
| Becton, Dickinson and Company | $17.18 | 2023 | Bd Onclarity |
| Coopersurgical, INC. | $15.30 | 2021 | |
| Avion Pharmaceuticals | $14.76 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.